Generic and specific recurrent neural network models: Applications for large and small scale biopharmaceutical upstream processes

Jens Smiatek(University of Stuttgart), Erich Bluhmki(Boehringer Ingelheim (Germany)), Thomas Wucherpfennig(Boehringer Ingelheim (Australia)), Liliana Montano-Herrera(Boehringer Ingelheim (Germany)), Alexander Jung(Boehringer Ingelheim (Germany)), Bettina L. Knapp(University of Freiburg), Beate Presser(Boehringer Ingelheim (Germany)), Christoph Clemens(Boehringer Ingelheim (Germany)), Sabine Arnold(Boehringer Ingelheim (Germany))
Biotechnology Reports
May 28, 2021
10.1016/j.btre.2021.e00640
Cited by 31

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
|Stroke|2006|236
In-line monitoring of thermal degradation of PHA during melt-processing by Near-Infrared spectroscopy
|New Biotechnology|2013|53
Fluxes in PHA-storing microbial communities during enrichment and biopolymer accumulation processes
|New Biotechnology|2015|47
Value-added bioplastics from services of wastewater treatment
|Water Practice & Technology|2015|31